| Structure |
Chemical Name |
CAS |
MF |
 |
N-Methyl Pantoprazole, mixture of 1 and 3 isomers |
624742-53-6 |
C17H17F2N3O4S |
 |
Pranoprofen Impurity 5 |
145986-74-9 |
C16H15NO3 |
 |
Avibactam Impurity X |
|
|
 |
Almotriptan Impurity 1 |
334981-13-4 |
C17H25N3O3S |
 |
ENT-パロキソール |
389573-45-9 |
C13H18FNO |
 |
Cefdinir Impurity F (CP) |
|
|
 |
SALVIAMILTIORRHIZA |
|
|
 |
Avibactam Impurity 39 |
2089462-91-7 |
C15H22N2O3 |
 |
bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine |
1623104-92-6 |
C26H28ClNO2 |
 |
Apixaban Impurity 51 |
1620494-29-2 |
C33H32N4O5 |
 |
Peramivir dehydrated deacetylated impurity |
|
|
 |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
 |
Furosemide Impurity 4 |
|
C12H11ClN2O5S |
 |
Ibrutinib Impurity 27 |
2031255-26-0 |
C26H28N6O3 |
 |
Ibrutinib Impurity 15 |
1288338-97-5 |
C47H46N12O3 |
 |
Aprepitant |
170902-80-4 |
C20H18F7NO2 |
 |
Erlotinib Impurity 58 |
2246399-22-2 |
C10H12N2O3 |
![Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]-](/CAS/20200401/GIF/2356153-95-0.gif) |
Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2356153-95-0 |
C17H14F3N3O3S |
 |
N7-[(2-ヒドロキシエトキシ)メチル)グアニン |
91702-61-3 |
C8H11N5O3 |
 |
ビス(P-アセチルアミノフェニル)エーテル |
3070-86-8 |
C16H16N2O3 |
 |
(S)-Azelastine |
143228-85-7 |
C22H24ClN3O |
 |
Erlotinib Imp.18 |
|
|
![(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン](/CAS/GIF/80657-17-6.gif) |
(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン |
80657-17-6 |
C18H22O2 |
 |
Atracurium Impurity O |
|
|
 |
Ticagrelor Imp.Q |
|
|
 |
2-Pyrrolidinecarboxamide,1-(hydroxyacetyl)-,(S)-(9CI) |
96166-39-1 |
C7H12N2O3 |
![(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran)](/CAS/20200119/GIF/CB14713877.gif) |
(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran) |
|
C34H32Cl2O4 |
 |
Afatinib Impurity 50 |
|
|
 |
クエルセチン 3‐ルチノシド 7‐グルコシド |
30311-61-6 |
C33H40O21 |
 |
(S)-2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-5-nitroisoindoline-1,3-dione |
|
C20H20N2O8S |
 |
Cabozantinib Impurity H |
|
|
![sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H26FN3O6S.Na |
 |
impurity 37 |
|
|
 |
Vortioxetine iMpurity |
853745-55-8 |
C10H14BrClN2 |
 |
Faropenem Impurity D |
|
|
![Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-](/CAS/20150408/GIF/145591-80-6.gif) |
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- |
145591-80-6 |
C11H11NO3 |
 |
Tofacitinib Impurity 89 |
|
|
![IMp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-CarbaMate](/) |
IMp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-CarbaMate |
|
|
 |
Lacosamide Impurity – K |
|
|
 |
Sulbactam Impurity 2 |
111790-24-0 |
C8H13NO6S |
 |
Trifluridine Impurity C |
|
|
 |
"mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |
|
|
 |
Levetiracetam impurity 2 |
1341459-52-6 |
C8H17N3O2 |
 |
Vonoprazan Impurity B-2 |
|
|
 |
Paxlovid Impurity 15 |
|
|
 |
Sitagliptin IMpurity 1 |
|
|
 |
PraMipexole IMp.BI-II828BS |
|
C20H32N6S2 |
 |
Hydroxychloroquine Impurity 12 Hydrochloride |
2411340-31-1 |
C18H26ClN3O |
 |
Furosemide Impurity 6 |
74793-12-7 |
C12H10ClNO3 |
 |
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED |
911661-90-0 |
C21H13I6NO5 |
 |
N-Des-tetrahydrofuran N-(6,7-Dimethoxy-4,4a-dihydroquinazolin-4-amine) Alfuzosin |
928780-95-4 |
C24H30N8O4 |
 |
Levomilnacipran impurity |
|
|
 |
Relugolix Impurity 91 |
|
|
 |
デアセチルリファンピン |
16783-99-6 |
C41H56N4O11 |
 |
2-AMino-5-(trifluoroMethoxy)phenyl Thiocyanate |
1391054-04-8 |
C8H5F3N2OS |
 |
Isavuconazole Impurity 19 |
|
|
 |
lamivudine sulfoxide |
160552-55-6 |
C8H11N3O4S |
 |
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
 |
RebaMipide 2-Chloro IMpurity |
90098-06-9 |
C19H15ClN2O4 |
![Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy-](/CAS/20200611/GIF/28469-01-4.gif) |
Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy- |
28469-01-4 |
C21H28N2O5S |
 |
Sitagliptin Impurity 80 |
|
|
![3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, methyl ester, (αR,3R)-rel-](/CAS/20211123/GIF/2740235-22-5.gif) |
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, methyl ester, (αR,3R)-rel- |
2740235-22-5 |
C13H22N2O5 |
 |
N-(2,6-dimethylphenyl)nicotinamide |
84951-65-5 |
C14H14N2O |
 |
Fluvastatin N-Ethyl Sodium Salt (Fluvastatin Impurity) |
93936-64-2 |
C23H24FNO4.Na |
 |
1-ベンジル-N,4-ジメチルピペリジン-3-アミン |
384338-23-2 |
C14H22N2 |
 |
N-(4-methyl-3-(N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
|
C31H33N7O2 |
 |
Oseltamivir Impurity 110 |
|
|
 |
Trelagliptin Impurity SJ |
2087874-94-8 |
C40H42F2N10O6 |
 |
Ticagrelor Impurity 22 |
|
|
 |
Febuxostat Impurity 70 |
2418591-43-0 |
C16H16N2O3S |
 |
2-piperazine-4-amino-6,7-dimethoxyquinazoline Hydrochloride |
70843-11-7 |
C14H20ClN5O2 |
 |
1449029-77-9 |
1449029-77-9 |
C29H26N4O7 |
 |
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-rel- |
2184053-08-3 |
C17H17Cl2N |
![2-CHLOROMETHYL-5-TRIFLUOROMETHYL-[1,3,4]OXADIAZOLE](/CAS/GIF/723286-98-4.gif) |
2-CHLOROMETHYL-5-TRIFLUOROMETHYL-[1,3,4]OXADIAZOLE |
723286-98-4 |
C4H2ClF3N2O |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
Linagliptin Impurity C |
1791405-13-4 |
C15H20N6O2 |
 |
8-Methoxyquinolin-2(1H)-one |
22614-69-3 |
C10H9NO2 |
 |
Emtricitabine |
61548-81-0 |
C11H22O3S |
 |
Pitavastatin Impurity 46 |
|
|
 |
Pramipexole Impurity 10 |
|
|
 |
lithiuM 2-(4-(Methylsulfonyl)phenyl)acetate |
1421227-96-4 |
C9H11LiO4S |
 |
Tazobactam Impurity 5 |
115546-67-3 |
C21H20ClNO3S |
 |
Avatrombopag Impurity 59 |
|
|
 |
N-Desmethyl Clarithromycin |
101666-68-6 |
C37H67NO13 |
![3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/1187595-89-6.gif) |
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- |
1187595-89-6 |
C17H19N7O3S |
![(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20180629/GIF/CB03954746.gif) |
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C23H29FN6O4S |
 |
Oxytocin Impurity 3 |
|
|
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-](/CAS/20180629/GIF/132810-75-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
132810-75-4 |
C23H31N3 |
 |
Pazufloxacin |
127046-18-8 |
C18H19FN2O4 |
 |
2-(hydroxy(phenyl)methyl)-N-(2-hydroxyethyl)benzamide |
|
|
 |
Tofacitinib Impurity 6 |
1640972-35-5 |
C16H22N6O |
 |
Fosaprepitant Impurity 1 |
172822-01-4 |
C23H22F7N4O6P |
 |
Deschloro Cetirizine Dihydrochloride |
83881-54-3 |
C21H26N2O3 |
 |
Azilsartan iMpurity N |
2244031-86-3 |
C22H17N3O4 |
 |
Deferasirox IMpurity 2 |
|
|
 |
Pidotimod Impurity L |
|
|
 |
Roxadustat Impurity 22 |
|
|
 |
Dapagliflozin Impurity 10 |
461432-27-9 |
C21H25ClO7 |
 |
Bimatoprost Impurity 9 |
|
|